Sign in
4/A

Changes in Ownership

Evofem Biosciences, Inc. Filed Acc 0001209191-15-066382

VP, Pharma Dev & Manufacturing acquired 1,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kemmerer Christopher VP, Pharma Dev & Manufacturing 2015-08-07 Option exercise +1,000 $1.34 $1,342 11,848 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kemmerer Christopher VP, Pharma Dev & Manufacturing 2015-08-07 Option exercise · Stock Option (Right to Buy) −1,000 51,182 D: show line 2 in the form
Loading xslF345X03/doc4a.xml…